Acquiring Company
Pfizer
Acquired Company
Global Blood Therapeutics
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticalsBiotechnologyHealth CareTherapeuticsDescription
Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities starting with sickle cell disease (SCD). The acquisition reinforces Pfizer’s commitment to SCD, building on a 30-year legacy in the rare hematology space.
Quick answer
Pfizer is acquiring Global Blood Therapeutics, announced October 5, 2022. Pfizer is based in New York, New York, United States.
- How much did Pfizer pay for Global Blood Therapeutics?
- The deal value was not disclosed.
- Where are Pfizer and Global Blood Therapeutics based?
- Pfizer is based in New York, New York, United States.
- Who are the decision-makers at Pfizer?
- Fundz holds 2 contacts at Pfizer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Pfizer Completes Acquisition Of Biohaven Pharmaceuticals (October 3, 2022)
- Atossa Therapeutics, Inc. To Acquire Stake In Privately Held Dynamic Cell Therapies As Part Of Overall Car-T Strategy (November 1, 2022)
- Sumitovant Biopharma And Sumitomo Pharma Announce Offer To Acquire Outstanding Shares Of Myovant Sciences (October 2, 2022)
- Amgen Successfully Completes Acquisition Of Chemocentryx (October 20, 2022)
- Lilly To Acquire Akouos To Discover And Develop Treatments For Hearing Loss (October 18, 2022)
- Incyte Announces Agreement To Acquire Medicxi-Backed Villaris Therapeutics And Auremolimab (Vm6), An Anti-Il-15Rβ Monoclonal Antibody (October 3, 2022)
Who to call at Pfizer, and when
When Pfizer changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Pfizer raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pfizer, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pfizer. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pfizer makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Global Blood Therapeutics?
Global Blood Therapeutics was acquired by Pfizer, based in New York. The deal was reported on October 5, 2022. Pfizer is publicly traded (PFE) and operates in Biotechnology.
When did Pfizer acquire Global Blood Therapeutics?
Pfizer's acquisition of Global Blood Therapeutics was reported on October 5, 2022. Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Global Blood Therapeutics, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Global Blood Therapeutics do?
Global Blood Therapeutics, Inc. (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities, starting with sickle cell disease (SCD). It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.